RxDoctor Payments Data

R Williams

Cardiovascular Disease · Durham, NCNPI 1982753901

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,000,182 of the $2,141,887 with a category attached, or 93.4%. Amgen accounts for 68.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $538,359 and has fallen 98.4% since, to $8,691 in 2025. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,141,887in general payments, 2019–2025

Across 392 payments — averaging $5464.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1.5M
  • Bristol Myers Squibb$496K
  • E.r. Squibb & Sons, L.L.C.$183K

What the payments were for

  • Consulting fees$8,5990%
  • Speaking & faculty fees$2,000,18293%
  • Travel & lodging$88,4974%
  • Food & beverage$44,6092%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen385$1,463,450
Bristol Myers Squibb5$495,543
E.r. Squibb & Sons, L.L.C.2$182,895

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,141,887 in reported general payments places this provider in the 95th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina

Other cardiovascular disease in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →